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1. Introduction
Refractory focal epilepsy following acute febrile encephalopa-
thy, also called fever-induced refractory epileptic encephalopathy
in school-aged children or febrile infection-related epilepsy
syndrome (FIRES), is a topic of great interest and is a newly
described condition in Europe and Asia. In a recent review,
Nabbout et al. termed this entity ‘‘acute encephalopathy with
inﬂammation-mediated status epilepticus (AEIMSE)’’.1
In the last few years, we have diagnosed and treated some
patients affected by this condition and showing a similar clinical
course.2,3 In the present report, we review various literature data
and add a few concepts regarding the differential diagnosis and the
possible role of inﬂammation and loss of function of the blood-
brain barrier (BBB) in the pathogenesis of the disease.
2. Acute and chronic phases
First, we propose to differentiate the disease into 2 main
phases: acute and chronic. The acute phase is characterized by the
encephalopathy period, in which at least 1 of the following
symptoms or signs is continuously present from the onset:
seizures, fever, soporous state, confusion, or neurological deﬁcits.
The chronic phase, which occurs immediately after the acute
phase, is deﬁned as a state of enduring drug-resistant focal
epilepsy.2,3
In our opinion, recognition of and distinction between the 2
phases is important because these 2 phases require different
treatment strategies. Moreover, the duration of the acute phase
might better characterize the prognosis in terms of seizure
frequency and cognitive and motor outcome; we agree with
Nabbout et al. regarding this deﬁnition.
3. Differential diagnosis
In all reported patients, the clinical onset resembled an infective
cerebral disease, characterized by disturbances of consciousness
and multifocal seizures. Differential diagnosis should exclude
limbic encephalitis and Alper’s disease.1 A similar stormy onset has
been recently identiﬁed for other chronic epilepsies, particularly in
female patients with protocadherin 19 (PCDH19) mutations. In
such cases, seizure onset could be related to a febrile illness; status
epilepticus at onset is frequent, and cognitive stagnation and
deterioration might be evident soon after.4 Therefore, we suggest
that selected female patients with AEIMSE should be tested for
point mutations of the PCDH19 gene; however, most of these
children are infants. In addition, most children with FIRES had no1059-1311/$ – see front matter  2011 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2011.07.005reported febrile seizures; almost all had status epilepticus at onset,
and the following epilepsy was more severe than that in patients
with PCDH19 mutations, some of whom showed prolonged
seizure-free periods during the follow-up.
In most of our patients, brain magnetic resonance imaging
(MRI) ﬁndings were not informative.1 However, in a few cases, we
found hyperintensity in the peri-insular areas.2 None of our
patients presented with bulging of the mesial temporal structures,
T2 hyperintensity, or bilateral temporo-mesial atrophy.1
Blood and CSF examination did not reveal infections; however,
we found oligoclonal bands and intrathecal IgG synthesis in almost
30% of our patients.2 This pattern suggests a local B-cell response
accompanying an ongoing inﬂammatory process and a BBB
disruption, which might lead to acute seizures in humans and
animal models.5
4. Therapeutic approach
The reported therapeutic approaches for patients with AEIMSE
have not been widely accepted, and different therapeutic
strategies have been proposed, most of them with inconstant
results. Benzodiazepines, barbiturates, and phenytoin showed
poor results, and the use of speciﬁc anti-inﬂammatory medications
is controversial; however, a ketogenic diet has been suggested to
have a beneﬁcial effect.1
Unfortunately, we cannot conﬁrm these results, because the
ketogenic diet showed no effect in 2 of our AEIMSE patients.
Moreover, we wonder whether patients who are intubated and
probably treated with pentothal or propofol have good gastroin-
testinal transit and absorption. Treatment with methylpredniso-
lone along with intravenous immunoglobulin (IVIG) might
improve the outcome both in terms of seizure frequency and
cognitive functions,2,3 particularly if these drugs are used early in
the disease course. Future trials with cyclophosphamide or
rituximab should be considered to collect sufﬁcient data on their
efﬁcacy, because these drugs may modify the disease course.
5. Conclusion
In most patients, neurological symptoms are preceded by
various viral infections that are responsible for fever. These viral
infections are not directly related to the pathogenesis of AEIMSE
but probably activate an immune- or inﬂammation-mediated
condition that determines appearance of seizures and other
neurological sequelae.
The characteristics of seizures at the onset (high frequency up
to status epilepticus, multifocal predominance, alternating side,
and predominantly slow activity on electroencephalograms
[EEGs]) appeared to remain unvaried during the chronic phase,
although with a milder course; these ﬁndings along with the
cognitive outcome result in a relatively unique electro-clinicalvier Ltd. All rights reserved.
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clarify the pathogenetic role of inﬂammation and more appropri-
ate therapeutic strategies.
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